Cargando…

Mifepristone Increases the Cytotoxicity of Uterine Natural Killer Cells by Acting as a Glucocorticoid Antagonist via ERK Activation

BACKGROUND: Mifepristone (RU486), a potent antagonist of progesterone and glucocorticoids, is involved in immune regulation. Our previous studies demonstrated that mifepristone directly augments the cytotoxicity of human uterine natural killer (uNK) cells. However, the mechanism responsible for this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yuezhou, Wang, Yan, Zhuang, Yaling, Zhou, Feng, Huang, Lili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3341349/ https://www.ncbi.nlm.nih.gov/pubmed/22563497 http://dx.doi.org/10.1371/journal.pone.0036413

Ejemplares similares

Effects of Ketoconazole on the Pharmacokinetics of Mifepristone, a Competitive Glucocorticoid Receptor Antagonist, in Healthy Men
por: Nguyen, Dat, et al.
Publicado: (2017)

Alcohol dependence and withdrawal increase sensitivity of central amygdalar GABAergic synapses to the glucocorticoid receptor antagonist mifepristone in male rats
por: Khom, Sophia, et al.
Publicado: (2022)

The use of mifepristone in abortion associated with an increased risk of uterine leiomyomas
por: Shen, Qi, et al.
Publicado: (2017)

Protective effects of glucocorticoid receptor antagonist Mifepristone on fear memory extinction impairment in a rat model of PTSD
por: Liu, Y.-P., et al.
Publicado: (2022)

Uterine Natural Killer Cells
por: Sojka, Dorothy K., et al.
Publicado: (2019)

Primary Generalized Glucocorticoid Hypersensitivity Treated with Mifepristone: A Case Report
por: Liu, Yunfeng, et al.
Publicado: (2020)

Glucocorticoid Receptor Antagonist Mifepristone Does Not Alter Innate Anxiety-Like Behavior in Genetically-Selected Marchigian Sardinian (msP) Rats
por: Vozella, Valentina, et al.
Publicado: (2021)

Two cases of infantile-onset primary generalized glucocorticoid hypersensitivity and the effect of mifepristone
por: Zhao, Xiu, et al.
Publicado: (2022)

Effect of mifepristone (25 mg) in treatment of uterine myoma in perimenopausal woman
por: Seth, Shikha, et al.
Publicado: (2013)

Mifepristone inhibits IGF-1 signaling pathway in the treatment of uterine leiomyomas
por: Shen, Qi, et al.
Publicado: (2019)

Mifepristone Plasma Level and Glucocorticoid Receptor Antagonism Associated With Response in Patients With Psychotic Depression
por: Block, Thaddeus, et al.
Publicado: (2017)

TWEAK Appears as a Modulator of Endometrial IL-18 Related Cytotoxic Activity of Uterine Natural Killers
por: Petitbarat, Marie, et al.
Publicado: (2011)

Insights into the paracrine effects of uterine natural killer cells
por: GONG, XIN, et al.
Publicado: (2014)

Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma
por: Di Giorgio, Cristina, et al.
Publicado: (2022)

Relative expression of receptors in uterine natural killer cells compared to peripheral blood natural killer cells
por: Ismail, Nurul Izza
Publicado: (2023)

Development and validation of an immunohistochemistry assay to assess glucocorticoid receptor expression for clinical trials of mifepristone in breast cancer
por: Baker, Gabrielle M, et al.
Publicado: (2015)

Mifepristone (RU486) inhibits dietary lipid digestion by antagonizing the role of glucocorticoid receptor on lipase transcription
por: Ma, Peng, et al.
Publicado: (2021)

Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine
por: Capellino, Silvia, et al.
Publicado: (2020)

Mifepristone-Induced Hypothyroidism
por: Kalara, Niketa, et al.
Publicado: (2023)

Mifepristone versus placebo to treat uterine myoma: a double-blind, randomized clinical trial
por: Esteve, Josep Lluis Carbonell, et al.
Publicado: (2013)

Influence of Atopic Dermatitis on Reproduction and Uterine Natural Killer Cells
por: HAYASHI, Kazuhiko, et al.
Publicado: (2014)

Uterine natural killer cells: Time for a re-appraisal?
por: Bulmer, Judith N., et al.
Publicado: (2019)

Biology and pathology of the uterine microenvironment and its natural killer cells
por: Wang, Fuyan, et al.
Publicado: (2021)

Novel RU486 (mifepristone) analogues with increased activity against Venezuelan Equine Encephalitis Virus but reduced progesterone receptor antagonistic activity
por: DeBono, Aaron, et al.
Publicado: (2019)

Cystatin F Affects Natural Killer Cell Cytotoxicity
por: Perišić Nanut, Milica, et al.
Publicado: (2017)

A Single-Day Treatment with Mifepristone Is Sufficient to Normalize Chronic Glucocorticoid Induced Suppression of Hippocampal Cell Proliferation
por: Hu, Pu, et al.
Publicado: (2012)

Non-Genetically Improving the Natural Cytotoxicity of Natural Killer (NK) Cells
por: Villalba, Martin, et al.
Publicado: (2020)

Different dosages of mifepristone versus enantone to treat uterine fibroids: A multicenter randomized controlled trial
por: Liu, Chongdong, et al.
Publicado: (2017)

Killer Timing: The Temporal Uterine Natural Killer Cell Differentiation Pathway and Implications for Female Reproductive Health
por: Fraser, Rupsha, et al.
Publicado: (2022)

Lactic Acid Bacteria from Kefir Increase Cytotoxicity of Natural Killer Cells to Tumor Cells
por: Yamane, Takuya, et al.
Publicado: (2018)

Increased Natural Killer Cells Are Associated with Alcohol Liver Fibrosis and with T Cell and Cytotoxic Subpopulations Change
por: Zuluaga, Paola, et al.
Publicado: (2022)

Role of Uterine Natural Killer Cells and Interferon γ in Placental Development
por: Redline, Raymond W.
Publicado: (2000)

Uterine Natural Killer Cell Heterogeneity: Lessons From Mouse Models
por: Sojka, Dorothy K.
Publicado: (2020)

α-Pinene Enhances the Anticancer Activity of Natural Killer Cells via ERK/AKT Pathway
por: Jo, Hantae, et al.
Publicado: (2021)

Resistance to cisplatin does not affect sensitivity of human ovarian cancer cell lines to mifepristone cytotoxicity
por: Freeburg, Elizabeth M, et al.
Publicado: (2009)

Natural killer cells act as rheostats modulating antiviral T cells
por: Waggoner, Stephen N., et al.
Publicado: (2011)

Natural killer cells act as an extrinsic barrier for in vivo reprogramming
por: Melendez, Elena, et al.
Publicado: (2022)

Impact of polysialylated CD56 on natural killer cell cytotoxicity
por: Moebius, Jeannette M, et al.
Publicado: (2007)

Fas-mediated cytotoxicity by freshly isolated natural killer cells
Publicado: (1995)

Natural Killer Cell Mediated Cytotoxic Responses in the Tasmanian Devil
por: Brown, Gabriella K., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_g24bfmu9jivjm1sfu3f7gs4255